Title : Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.

Pub. Date : 1980 Jan

PMID : 7188615






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 It has recently been claimed that the PRL-lowering response to nomifensine administration (200 mg, orally) reliably discriminates patients with PRL-secreting tumors from those with so-called functional hyperprolactinemia. Nomifensine prolactin Homo sapiens
2 It has recently been claimed that the PRL-lowering response to nomifensine administration (200 mg, orally) reliably discriminates patients with PRL-secreting tumors from those with so-called functional hyperprolactinemia. Nomifensine prolactin Homo sapiens
3 The decrease of mean serum PRL concentration after nomifensine was only significant in the first and second groups. Nomifensine prolactin Homo sapiens
4 Analysis of variance showed a significant difference in the PRL inhibition by nomifensine between the tumor group and the two groups without evidence of pituitary adenoma. Nomifensine prolactin Homo sapiens